Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.
Identifieur interne : 002030 ( Ncbi/Curation ); précédent : 002029; suivant : 002031Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.
Auteurs : Robert A. Hauser [États-Unis] ; C Warren Olanow [États-Unis] ; Bruce Dzyngel [Canada] ; Thierry Bilbault [Canada] ; Holly Shill [États-Unis] ; Stuart Isaacson [États-Unis] ; Jordan Dubow [Canada] ; Albert Agro [Canada]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2016.
Abstract
OFF episodes negatively impact quality of life in patients with Parkinson's disease (PD). There remains a need for an acute, effective, noninvasive treatment.
DOI: 10.1002/mds.26697
PubMed: 27430123
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000168
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000168
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000168
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002030
Links to Exploration step
pubmed:27430123Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="2"><nlm:affiliation>University of South Florida Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, Tampa, Florida, USA. rhauser@health.usf.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of South Florida Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dzyngel, Bruce" sort="Dzyngel, Bruce" uniqKey="Dzyngel B" first="Bruce" last="Dzyngel">Bruce Dzyngel</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bilbault, Thierry" sort="Bilbault, Thierry" uniqKey="Bilbault T" first="Thierry" last="Bilbault">Thierry Bilbault</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shill, Holly" sort="Shill, Holly" uniqKey="Shill H" first="Holly" last="Shill">Holly Shill</name>
<affiliation wicri:level="2"><nlm:affiliation>Barrow Neurological Institute, Phoenix, Arizona, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Barrow Neurological Institute, Phoenix, Arizona</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Isaacson, Stuart" sort="Isaacson, Stuart" uniqKey="Isaacson S" first="Stuart" last="Isaacson">Stuart Isaacson</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubow, Jordan" sort="Dubow, Jordan" uniqKey="Dubow J" first="Jordan" last="Dubow">Jordan Dubow</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Agro, Albert" sort="Agro, Albert" uniqKey="Agro A" first="Albert" last="Agro">Albert Agro</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27430123</idno>
<idno type="pmid">27430123</idno>
<idno type="doi">10.1002/mds.26697</idno>
<idno type="wicri:Area/PubMed/Corpus">000168</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000168</idno>
<idno type="wicri:Area/PubMed/Curation">000168</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000168</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000168</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000168</idno>
<idno type="wicri:Area/Ncbi/Merge">002030</idno>
<idno type="wicri:Area/Ncbi/Curation">002030</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.</title>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="2"><nlm:affiliation>University of South Florida Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, Tampa, Florida, USA. rhauser@health.usf.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of South Florida Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dzyngel, Bruce" sort="Dzyngel, Bruce" uniqKey="Dzyngel B" first="Bruce" last="Dzyngel">Bruce Dzyngel</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bilbault, Thierry" sort="Bilbault, Thierry" uniqKey="Bilbault T" first="Thierry" last="Bilbault">Thierry Bilbault</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shill, Holly" sort="Shill, Holly" uniqKey="Shill H" first="Holly" last="Shill">Holly Shill</name>
<affiliation wicri:level="2"><nlm:affiliation>Barrow Neurological Institute, Phoenix, Arizona, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Barrow Neurological Institute, Phoenix, Arizona</wicri:regionArea>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Isaacson, Stuart" sort="Isaacson, Stuart" uniqKey="Isaacson S" first="Stuart" last="Isaacson">Stuart Isaacson</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubow, Jordan" sort="Dubow, Jordan" uniqKey="Dubow J" first="Jordan" last="Dubow">Jordan Dubow</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Agro, Albert" sort="Agro, Albert" uniqKey="Agro A" first="Albert" last="Agro">Albert Agro</name>
<affiliation wicri:level="1"><nlm:affiliation>Cynapsus Therapeutics, Inc, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Cynapsus Therapeutics, Inc, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OFF episodes negatively impact quality of life in patients with Parkinson's disease (PD). There remains a need for an acute, effective, noninvasive treatment.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002030 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002030 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:27430123 |texte= Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:27430123" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |